Related Experiment Video
Updated: Aug 23, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Treating nicotine use and dependence of pregnant and parenting smokers: an update
Cathy Melvin1, Cecelia Gaffney
1University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7590, USA. cathy_melvin@unc.edu
Abstract:
A growing volume of research since 1975 has demonstrated that clinically proven, effective interventions exist to produce long-term or even permanent abstinence from tobacco for all smokers. Achieving cessation is important for all smokers but especially for pregnant and parenting smokers because their smoking poses risks not only for themselves but also for their pregnancies and children. Treatments for smokers in general apply to parenting smokers, but special considerations regarding treatment need to be made for pregnant women. Due to the harms associated with exposure to environmental tobacco smoke, or second-hand smoke (SHS), parents and caregivers of young children should receive treatment to achieve cessation or counseling on how to eliminate exposure of children to SHS. Despite the availability of these treatments, surveys show that fewer than half of all obstetricians caring for pregnant women in the United States actually provide such treatment. We review the recommendations made in 2000 regarding treatment for pregnant and parenting smokers, summarize recent findings that may affect treatment protocols, and make recommendations regarding further research in treatment approaches for pregnant and parenting smokers. We summarize recommended changes in treatment approaches for clinicians based on this review and describe the factors affecting clinician adoption and use of proven treatments and systems supports found to increase the likelihood of clinician use of these treatments.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence
Stress Prevention and Stress Management Techniques IV
